These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis, biological evaluation and molecular modeling studies of novel 1,2,3-triazole-linked menadione-furan derivatives as P2X7 inhibitors. Dos Santos JPS; Ribeiro RCB; Faria JV; Bello ML; Lima CGS; Pauli FP; Borges AA; Rocha DR; Moraes MG; Forezi LSM; Ferreira VF; Faria RX; da Silva FC J Bioenerg Biomembr; 2022 Dec; 54(5-6):227-239. PubMed ID: 36070071 [TBL] [Abstract][Full Text] [Related]
7. Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response. Faria RX; de Jesus Hiller N; Salles JP; Resende JALC; Diogo RT; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; de Luna Martins D J Bioenerg Biomembr; 2019 Aug; 51(4):277-290. PubMed ID: 31256283 [TBL] [Abstract][Full Text] [Related]
12. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket. Bin Dayel A; Evans RJ; Schmid R Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019 [TBL] [Abstract][Full Text] [Related]